Fundz

Advanced Nanotherapies Announces Closing Of Oversubscribed $7.2 Million Series A Financing

PRIVATEJun 28, 2022

Amount Raised

$7.2 Million

Round Type

Series A

Los GatosManufacturingBiotechnologyHealth CareScience And Engineering

Description

Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease's most significant challenges through the creative applications of nanotechnology, today announced the closing of its oversubscribed $7.2 million Series A equity financing, marking a total of $12.5 million raised since September 2020. Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon (DCB) in de-novo coronary artery disease (CAD) lesions. Funding comes from various sources in the U.S., Canada, Europe, and Asia.

Quick answer

Advanced NanoTherapies raised $7.2 Million in a Series A round, dated June 28, 2022. Advanced NanoTherapies is based in Los Gatos, California, United States.

How much did Advanced NanoTherapies raise?
Advanced NanoTherapies raised $7.2 Million in a Series A round on June 28, 2022.
What does Advanced NanoTherapies do?
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention.
Where is Advanced NanoTherapies based and how big is it?
Advanced NanoTherapies is based in Los Gatos, California, United States. Fundz records about 17 employees.
Who are the decision-makers at Advanced NanoTherapies?
Fundz holds 1 contact at Advanced NanoTherapies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Manufacturing around the same time

Companies in the same sectors as Advanced NanoTherapies that raised within 45 days of this round, from Fundz verified event records.

  • 22nd Century raised $35M on July 21, 2022.
  • 22nd Century raised $58M on May 25, 2022.
  • Levita Magnetics International Corp. raised $26M (Funding Round) on August 11, 2022.
  • REVA Medical raised an undisclosed amount (Funding Round) on August 9, 2022.
  • BNB Plus raised $3.6M (Seed) on August 9, 2022.
  • Talphera, Inc. raised $630K on August 3, 2022.

Who to call at Advanced NanoTherapies, and when

A new round usually means Advanced NanoTherapies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Advanced NanoTherapies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Advanced NanoTherapies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Advanced NanoTherapies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Advanced NanoTherapies

Location

Los Gatos, California, United States

About

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Advanced NanoTherapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Advanced NanoTherapies. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Advanced NanoTherapies's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Advanced NanoTherapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.